You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial

Citation Tools

Article menu

Download PDFPDF

Infectious diseases
Protocol
Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sohani ZN, Butler-Laporte G, Aw A, et al
Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial
BMJ Open 2022;12:e053039. doi: 10.1136/bmjopen-2021-053039